R01 AG018402/AG/NIA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2003	2
2005	2
2006	1
2007	2
2008	6
2009	7
2010	2
2011	1
2012	5
2013	2
2024	0

1

Development of positron emission tomography β-amyloid plaque imaging agents.

Mathis CA, Mason NS, Lopresti BJ, Klunk WE. Mathis CA, et al. Semin Nucl Med. 2012 Nov;42(6):423-32. doi: 10.1053/j.semnuclmed.2012.07.001. Semin Nucl Med. 2012. PMID: 23026364 Free PMC article. Review.

2

Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

Cohen AD, Rabinovici GD, Mathis CA, Jagust WJ, Klunk WE, Ikonomovic MD. Cohen AD, et al. Adv Pharmacol. 2012;64:27-81. doi: 10.1016/B978-0-12-394816-8.00002-7. Adv Pharmacol. 2012. PMID: 22840744 Free PMC article. Review.

3

Molecular brain imaging in the multimodality era.

Price JC. Price JC. J Cereb Blood Flow Metab. 2012 Jul;32(7):1377-92. doi: 10.1038/jcbfm.2012.29. Epub 2012 Mar 21. J Cereb Blood Flow Metab. 2012. PMID: 22434068 Free PMC article. Review.

4

The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation.

Klunk WE, Mathis CA. Klunk WE, et al. Curr Opin Neurol. 2008 Dec;21(6):683-7. doi: 10.1097/WCO.0b013e3283168e1a. Curr Opin Neurol. 2008. PMID: 18989113 Free PMC article. Review.

5

Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET.

Rosario BL, Weissfeld LA, Laymon CM, Mathis CA, Klunk WE, Berginc MD, James JA, Hoge JA, Price JC. Rosario BL, et al. Neuroimage. 2011 Apr 1;55(3):933-41. doi: 10.1016/j.neuroimage.2010.12.070. Epub 2010 Dec 31. Neuroimage. 2011. PMID: 21195782 Free PMC article.

6

Impact of amyloid imaging on drug development in Alzheimer's disease.

Mathis CA, Lopresti BJ, Klunk WE. Mathis CA, et al. Nucl Med Biol. 2007 Oct;34(7):809-22. doi: 10.1016/j.nucmedbio.2007.06.015. Epub 2007 Sep 4. Nucl Med Biol. 2007. PMID: 17921032 Free PMC article. Review.

7

In vivo assessment of amyloid-β deposition in nondemented very elderly subjects.

Mathis CA, Kuller LH, Klunk WE, Snitz BE, Price JC, Weissfeld LA, Rosario BL, Lopresti BJ, Saxton JA, Aizenstein HJ, McDade EM, Kamboh MI, DeKosky ST, Lopez OL. Mathis CA, et al. Ann Neurol. 2013 Jun;73(6):751-61. doi: 10.1002/ana.23797. Epub 2013 Apr 17. Ann Neurol. 2013. PMID: 23596051 Free PMC article. Clinical Trial.

8

Imaging amyloid deposition in Lewy body diseases.

Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA. Gomperts SN, et al. Neurology. 2008 Sep 16;71(12):903-10. doi: 10.1212/01.wnl.0000326146.60732.d6. Neurology. 2008. PMID: 18794492 Free PMC article.

9

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Shao L, Hamilton RL, Ikonomovic MD, DeKosky ST, Mathis CA. Klunk WE, et al. J Neurosci. 2003 Mar 15;23(6):2086-92. doi: 10.1523/JNEUROSCI.23-06-02086.2003. J Neurosci. 2003. PMID: 12657667 Free PMC article.

10

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

Wiley CA, Lopresti BJ, Venneti S, Price J, Klunk WE, DeKosky ST, Mathis CA. Wiley CA, et al. Arch Neurol. 2009 Jan;66(1):60-7. doi: 10.1001/archneurol.2008.511. Arch Neurol. 2009. PMID: 19139300 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

28 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year